NASDAQ, OBSV #Reorganization #Trending News ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland February 24, 2023 01:00 EST Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – February 24, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced a strategic reorganization that will consolidate operations in Switzerland so No Comments
JNCE, NASDAQ #Cancer #Featured #Reorganization #Trending News Jounce Therapeutics Announces Restructuring February 22, 2023 17:00 EST CAMBRIDGE, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (Nasdaq: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, announced today that it is reducing its workforce by approximately 57 percent. The decision to reduce its workforce was made No Comments
NASDAQ, TPIC #Financial Data #Reorganization #Trending News TPI Composites, Inc. Delivers Solid Close to a Challenging Year – Restructuring Plans on Track to Position TPI for the Future February 22, 2023 16:31 EST SCOTTSDALE, Ariz., Feb. 22, 2023 (GLOBE NEWSWIRE) — TPI Composites, Inc. (Nasdaq: TPIC), today reported financial results for the fourth quarter and full year ended December 31, 2022. “We finished 2022 strong and I am proud of our team for the results TPI delivered in a very challenging operating No Comments
GRPH, NASDAQ #Discontinuation #Featured #Reorganization #Trending News Graphite Bio Announces Process to Explore Strategic Alternatives and Corporate Restructuring February 22, 2023 16:05 EST SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Graphite Bio, Inc. (Nasdaq: GRPH) today announced that it has completed a review of its business, including the status of its programs, resources and capabilities. The company has decided to discontinue further development of nulabeglogene autogedtemcel (nula-cel) for sickle cell disease and to initiate a No Comments
ALKFF, OTC #Loan #Reorganization Alkaline Fuel Cell Power Corp. Completes Loan Restructuring February 21, 2023 16:05 EST TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) — Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) (“PWWR” or the “Company”), a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, announces that it has successfully negotiated a restructuring of a promissory note (the No Comments
MMNFF, OTC #Cannabis #Reorganization MedMen Continues Restructuring Efforts, Highlights Results To-Date, and Announces Strategic Review of Assets in Arizona, Illinois, and Nevada as Next Steps February 17, 2023 17:55 EST LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, continues to make progress in its restructuring efforts. Efforts to date have been effective, resulting in a return to positive adjusted EBITDA and a 34% reduction No Comments
NASDAQ, TALS #Discontinuation #kidney #Reorganization #Trending News Talaris Therapeutics Announces Plans to Explore Strategic Alternatives and Implements Restructuring Plan February 16, 2023 07:00 EST BOSTON and LOUISVILLE, Ky., Feb. 16, 2023 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS), today announced that it has completed a review of its business and program prospects. Based on this review, Talaris has decided to discontinue its FREEDOM-1 and FREEDOM-2 clinical trials evaluating FCR001’s ability to induce No Comments
BKUH, OTC #Reorganization Bakhu Holdings Principal Stockholders Agree to Future Restructuring to Support Proposed Financing February 15, 2023 14:10 EST LONG BEACH, CA / ACCESSWIRE / February 15, 2023 / Bakhu Holdings, Corp. (OTC Pink:BKUH) today announced that its principal stockholders – that control approximately 64.37% of Bakhu’s outstanding common stock and 87.75% of the combined voting power – have agreed to a corporate restructuring in an effort to No Comments
FCN, NYSE #Reorganization FTI Consulting Releases Second Edition of Directors’ and Officers’ Guide to Restructuring February 15, 2023 07:30 EST WASHINGTON, Feb. 15, 2023 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the publication of Navigating Today’s Environment | The Directors’ and Officers’ Guide to Restructuring (Second Edition), which examines key topics and challenges facing directors and officers leading distressed enterprises undergoing rapid change in today’s environment. No Comments
GDNSF, OTC #Cannabis #Reorganization Goodness Growth Holdings Announces Management Reorganization February 14, 2023 08:30 EST – Josh Rosen promoted to role of Interim Chief Executive Officer – – Company Founder, Dr. Kyle Kingsley, to assume role of Executive Chairman – – Decentralized state market teams designed to improve operating and financial performance – MINNEAPOLIS, Feb. 14, 2023 (GLOBE NEWSWIRE) — Goodness Growth Holdings, Inc. No Comments
Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock 02/23/2023
Columbia Banking System Set to Join S&P MidCap 400; Verra Mobility to Join S&P SmallCap 600 02/23/2023